These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 29955162)

  • 1. Endogenous opioid system dysregulation in depression: implications for new therapeutic approaches.
    Peciña M; Karp JF; Mathew S; Todtenkopf MS; Ehrich EW; Zubieta JK
    Mol Psychiatry; 2019 Apr; 24(4):576-587. PubMed ID: 29955162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous Opioids at the Intersection of Opioid Addiction, Pain, and Depression: The Search for a Precision Medicine Approach.
    Emery MA; Akil H
    Annu Rev Neurosci; 2020 Jul; 43():355-374. PubMed ID: 32109184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medicaid Expansion and Prescription Trends: Opioids, Addiction Therapies, and Other Drugs.
    Cher BAY; Morden NE; Meara E
    Med Care; 2019 Mar; 57(3):208-212. PubMed ID: 30629018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting opioid dysregulation in depression for the development of novel therapeutics.
    Browne CA; Lucki I
    Pharmacol Ther; 2019 Sep; 201():51-76. PubMed ID: 31051197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioid system modulation of cognitive affective bias: implications for the treatment of mood disorders.
    Varastehmoradi B; Wegener G; Sanchez C; Smith KL
    Behav Pharmacol; 2020 Apr; 31(2&3):122-135. PubMed ID: 32168024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Targets to Treat Depression: Opioid-Based Therapeutics.
    Browne CA; Jacobson ML; Lucki I
    Harv Rev Psychiatry; 2020; 28(1):40-59. PubMed ID: 31913981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study.
    Wei YJ; Chen C; Fillingim R; Schmidt SO; Winterstein AG
    PLoS Med; 2019 Nov; 16(11):e1002941. PubMed ID: 31689302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique and joint associations of polygenic risk for major depression and opioid use disorder with endogenous opioid system function.
    Love T; Shabalin AA; Kember RL; Docherty AR; Zhou H; Koppelmans V; Gelernter J; Baker AK; Hartwell E; Dubroff J; Zubieta JK; Kranzler HR
    Neuropsychopharmacology; 2022 Sep; 47(10):1784-1790. PubMed ID: 35545664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions.
    Martins SS; Fenton MC; Keyes KM; Blanco C; Zhu H; Storr CL
    Psychol Med; 2012 Jun; 42(6):1261-72. PubMed ID: 21999943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioidergic Agents as Antidepressants: Rationale and Promise.
    Saxena PP; Bodkin JA
    CNS Drugs; 2019 Jan; 33(1):9-16. PubMed ID: 30430396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns and history of prescription drug use among opioid-related drug overdose cases in British Columbia, Canada, 2015-2016.
    Smolina K; Crabtree A; Chong M; Zhao B; Park M; Mill C; Schütz CG
    Drug Alcohol Depend; 2019 Jan; 194():151-158. PubMed ID: 30439611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.
    Gomes T; Khuu W; Craiovan D; Martins D; Hunt J; Lee K; Tadrous M; Mamdani MM; Paterson JM; Juurlink DN
    Drug Alcohol Depend; 2018 Oct; 191():86-90. PubMed ID: 30096638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid modulation of depression: A focus on imaging studies.
    Rouine J; Callaghan CK; O'Mara SM
    Prog Brain Res; 2018; 239():229-252. PubMed ID: 30314568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergency Visits for Prescription Opioid Overdose.
    Ruan X; Bydalek K; Kaye AD
    Clin J Pain; 2016 May; 32(5):459. PubMed ID: 26626300
    [No Abstract]   [Full Text] [Related]  

  • 16. Opioid Analgesics in Georgia Medicaid: Trends in Potential Inappropriate Prescribing Practices by Demographic Characteristics, 2009-2014.
    Jayawardhana J; Abraham AJ; Perri M
    J Manag Care Spec Pharm; 2018 Sep; 24(9):886-894. PubMed ID: 30156455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of opioid modulation in major depressive disorder.
    Ehrich E; Turncliff R; Du Y; Leigh-Pemberton R; Fernandez E; Jones R; Fava M
    Neuropsychopharmacology; 2015 May; 40(6):1448-55. PubMed ID: 25518754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database.
    Green TC; Grimes Serrano JM; Licari A; Budman SH; Butler SF
    Drug Alcohol Depend; 2009 Jul; 103(1-2):65-73. PubMed ID: 19409735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Prescription Opioids Driving the Opioid Crisis? Assumptions vs Facts.
    Rose ME
    Pain Med; 2018 Apr; 19(4):793-807. PubMed ID: 28402482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fourth Wave of Opioid (Illicit Drug) Overdose Deaths and Diminishing Access to Prescription Opioids and Interventional Techniques: Cause and Effect.
    Manchikanti L; Singh VM; Staats PS; Trescot AM; Prunskis J; Knezevic NN; Soin A; Kaye AD; Atluri S; Boswell MV; Abd-Elsayed A; Hirsch JA
    Pain Physician; 2022 Mar; 25(2):97-124. PubMed ID: 35322965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.